Characteristics and survival of BCR/ABL negative chronic myeloid leukemia

A retrospective analysis of the Surveillance, Epidemiology and End Results database

Smith Giri, Ranjan Pathak, Michael Martin, Vijaya Raj Bhatt

Research output: Contribution to journalLetter

5 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)308-312
Number of pages5
JournalTherapeutic Advances in Hematology
Volume6
Issue number6
DOIs
StatePublished - Jan 1 2015

Fingerprint

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Epidemiology
Databases

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Characteristics and survival of BCR/ABL negative chronic myeloid leukemia : A retrospective analysis of the Surveillance, Epidemiology and End Results database. / Giri, Smith; Pathak, Ranjan; Martin, Michael; Bhatt, Vijaya Raj.

In: Therapeutic Advances in Hematology, Vol. 6, No. 6, 01.01.2015, p. 308-312.

Research output: Contribution to journalLetter

@article{863010be1b3c4214b0f840e1abf53a7e,
title = "Characteristics and survival of BCR/ABL negative chronic myeloid leukemia: A retrospective analysis of the Surveillance, Epidemiology and End Results database",
author = "Smith Giri and Ranjan Pathak and Michael Martin and Bhatt, {Vijaya Raj}",
year = "2015",
month = "1",
day = "1",
doi = "10.1177/2040620715607416",
language = "English (US)",
volume = "6",
pages = "308--312",
journal = "Therapeutic Advances in Hematology",
issn = "2040-6207",
publisher = "Sage Publications",
number = "6",

}

TY - JOUR

T1 - Characteristics and survival of BCR/ABL negative chronic myeloid leukemia

T2 - A retrospective analysis of the Surveillance, Epidemiology and End Results database

AU - Giri, Smith

AU - Pathak, Ranjan

AU - Martin, Michael

AU - Bhatt, Vijaya Raj

PY - 2015/1/1

Y1 - 2015/1/1

UR - http://www.scopus.com/inward/record.url?scp=84993736220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84993736220&partnerID=8YFLogxK

U2 - 10.1177/2040620715607416

DO - 10.1177/2040620715607416

M3 - Letter

VL - 6

SP - 308

EP - 312

JO - Therapeutic Advances in Hematology

JF - Therapeutic Advances in Hematology

SN - 2040-6207

IS - 6

ER -